Tenidap

This classification denotes a non-steroidal anti-inflammatory agent and cyclooxygenase inhibitor with the molecular formula C14H9ClN2O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9K7CJ74ONH, chemically known as 2,3-dihydro-5-chloro-2-oxo-3-(2-thienylcarbonyl)-1h-indole-1-carboxamide but generally known as tenidap, which bears US NIH Compound Identifier 57946. European Medicines Agency schedules Tenidap in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB15484MIG. World Health Organization schedules tenidap in its Anatomical Therapeutic Chemical (ATC) Classification. TENIDAP is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule tenidap under HS 29349990 and SITC 51579. As of Q4 2014, TENIDAP remains the US FDA Preferred Term for this commodity. SMILES: CLC1CC2C(C(=O)N(C2CC1)C(=O)N)C(=O)C1SCCC1.